Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02644291
Title Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

brain cancer

medulloblastoma

high grade glioma

Therapies

Mebendazole

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.